468 Individually dose-adjusted treatment with epirubicin and paclitaxel with or without capecitabine as 1st line treatment in metastatic breast cancer. A randomized multicenter trial
T. Hatschek, Z. Einbeigi, T. Walz, M. Malmberg, N. Loman, L. Carlsson, M. Söderberg, B. Linderholm, B. Lindh, M. SundqvistVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70489-4
File:
PDF, 67 KB
english, 2010